978P - Algorithms derived from quantitative pathology can be a gatekeeper in patient selection for clinical trials in localised clear cell renal cell carcinoma (ccRCC)

Autor: Um, I.H. 1, Scott-Hayward, L. 2, MacKenzie, M. 2, Tan, P.H. 3, Kanesvaran, R. 4, Choudhury, Y. 5, Tan, M.-H. 6, O’Donnell, M. 7, Caie, P.D. 8, Stewart, G.D. 9, Harrison, D.J. 10
Zdroj: In Annals of Oncology October 2019 30 Supplement 5:v397-v397
Databáze: ScienceDirect